Supporting Breakthrough Health Advancements in Eswatini Under the America First Global Health Strategy

Today, the United States and the Government of the Kingdom of Eswatini signed a five-year Memorandum of Understanding (MOU) on global health cooperation that includes strategic investments to strengthen national health efforts, leverage American technology, and facilitate the long-term sustainability of Eswatini’s health system.

The Department of State, working with Congress, intends to provide up to $205 million to improve public health data systems, modernize disease surveillance and outbreak response technology, provide access to HIV antiretroviral medications, and scale up access to highly effective HIV prevention interventions. Eswatini will continue to demonstrate its commitment to invest in strategic, catalytic, and innovative healthcare solutions by increasing domestic health expenditures by $37 million during the length of the $242 million MOU. These efforts also include the recently announced delivery of American-made lenacapavir, a breakthrough drug in HIV prevention.

The signing places Eswatini on a clear path to achieving the long-term goal of an effective, sustainable, and efficient health system while underscoring a mutual commitment to safeguarding health gains, protecting American and Eswatini citizens alike.